Evidence map›Paper›PMID 25365328›Full record

ArticlePloS one2014

Patient-based transcriptome-wide analysis identify interferon and ubiquination pathways as potential predictors of influenza A disease severity.

Long Truong Hoang, Thomas Tolfvenstam, Eng Eong Ooi, Chiea Chuen Khor, Ahmand Nazri Mohamed Naim, Eliza Xin Pei Ho, Swee Hoe Ong, Heiman F Wertheim, Annette Fox, Chau Van Vinh Nguyen and 17 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Immune Responses to Influenza Infection in Children.Open forum infectious diseases · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Establishment of a Risk Score Model for Early Prediction of Severe H1N1 Influenza.Frontiers in cellular and infection microbiology · 2021
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 12 institutions in 6 countries.

Long Truong HoangGenome Institute of Singapore, Singapore, Singapore.
Thomas TolfvenstamInfection Immunology, Respiratory Infections, Karolinska Institutet, Solna, Sweden.
Eng Eong OoiDepartment of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Chiea Chuen KhorGenome Institute of Singapore, Singapore, Singapore.
Ahmand Nazri Mohamed NaimGenome Institute of Singapore, Singapore, Singapore.
Eliza Xin Pei HoGenome Institute of Singapore, Singapore, Singapore.
Swee Hoe OngGenome Institute of Singapore, Singapore, Singapore.
Heiman F WertheimNational Hospital of Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Hanoi, Vietnam, and Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Annette FoxNational Hospital of Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Hanoi, Vietnam, and Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Chau Van Vinh NguyenHospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
Ngoc My NghiemHospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
Tuan Manh HaChildren Hospital 2, Ho Chi Minh City, Vietnam.
Anh Thi Ngoc TranChildren Hospital 2, Ho Chi Minh City, Vietnam.
Paul TambayahNational University Hospital, Singapore, Singapore.
Raymond LinNational University Hospital, Singapore, Singapore.
Chariya SangsajjaBamrasnaradura Infectious Disease Institute, Nonthaburi, Thailand.
Weerawat ManosuthiBamrasnaradura Infectious Disease Institute, Nonthaburi, Thailand.
Chareon ChuchottawornChest Disease Institute, Nonthaburi, Thailand.
Piamlarp SansayunhChest Disease Institute, Nonthaburi, Thailand.
Tawee ChotpitayasunondhQueen Sirikit National Institute of Child Health, Bangkok, Thailand.
Piyarat SuntarattiwongQueen Sirikit National Institute of Child Health, Bangkok, Thailand.
Kulkanya ChokephaibulkitFaculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Pilaipan PuthavathanaFaculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Menno D de JongThe Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam, and Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Jeremy FarrarThe Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam, and Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
H Rogier van DoornThe Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam, and Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Martin Lloyd HibberdGenome Institute of Singapore, Singapore, Singapore.
Genome Institute of Singapore · SGWellcome Trust · GBBamrasnaradura Infectious Diseases Institute · THCentral Chest Institute of Thailand · THChildren's Hospital 2 · VNHospital for Tropical Diseases · VNMahidol University · THNational University Hospital · SGOxford University Clinical Research Unit · VNQueen Sirikit National Institute of Child Health · THAcademic Medical Center · NLKarolinska Institutet · SE

Funding

Wellcome Trust 077078/Z/05/ZWellcome Trust 089276
6 · The paper itself

Abstract

backgroundThe influenza A virus is an RNA virus that is responsible for seasonal epidemics worldwide with up to five million cases of severe illness and 500,000 deaths annually according to the World Health Organization estimates. The factors associated with severe diseases are not well defined, but more severe disease is more often seen among persons aged >65 years, infants, pregnant women, and individuals of any age with underlying health conditions. METHODOLOGY/PRINCIPAL

findingsUsing gene expression microarrays, the transcriptomic profiles of influenza-infected patients with severe (N = 11), moderate (N = 40) and mild (N = 83) symptoms were compared with the febrile patients of unknown etiology (N = 73). We found that influenza-infected patients, regardless of their clinical outcomes, had a stronger induction of antiviral and cytokine responses and a stronger attenuation of NK and T cell responses in comparison with those with unknown etiology. More importantly, we found that both interferon and ubiquitination signaling were strongly attenuated in patients with the most severe outcomes in comparison with those with moderate and mild outcomes, suggesting the protective roles of these pathways in disease pathogenesis. CONCLUSION/SIGNIFICANCES: The attenuation of interferon and ubiquitination pathways may associate with the clinical outcomes of influenza patients.

Indexed as

Influenza A virusSignal TransductionTranscriptomeAdolescentAdultAgedComputational BiologyFemaleGene Expression ProfilingGene Expression RegulationHumansInfluenza, HumanInterferonsMaleMiddle AgedPrognosisInterferons

Identifiers

PMID25365328
PMCPMC4218794
OpenAlexW1992285484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.